trending Market Intelligence /marketintelligence/en/news-insights/trending/2rSaz72XdshKHYAZjlnvOQ2 content esgSubNav
In This List

Lupin CFO to resign

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Lupin CFO to resign

Lupin Ltd. said Ramesh Swaminathan would step down as the company's CFO in December.

The company said Swaminathan has decided to resign to pursue other responsibilities outside the pharmaceutical industry.

Mumbai, India-based Lupin is a pharmaceutical company that develops, produces, and markets a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients worldwide.